Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice

Por Polo, Maria Laura, Arnoni, Maria Victoria, Riggio, Marina, Wargon, Victoria, Lanari, Claudia, Novaro, Virginia
Publicado em 2010

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

Por Riggio, Marina, Perrone, María C., Polo, María L., Rodriguez, María J., May, María, Abba, Martín, Lanari, Claudia, Novaro, Virginia
Publicado no Sci Rep (2017)

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters

Por Wargon, Victoria, Riggio, Marina, Giulianelli, Sebastián, Sequeira, Gonzalo R., Rojas, Paola, May, María, Polo, María L., Gorostiaga, María A., Jacobsen, Britta, Molinolo, Alfredo, Novaro, Virginia, Lanari, Claudia
Publicado no Int J Cancer (2014)

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

Por Polo, María Laura, Riggio, Marina, May, María, Rodríguez, María Jimena, Perrone, María Cecilia, Stallings-Mann, Melody, Kaen, Diego, Frost, Marlene, Goetz, Matthew, Boughey, Judy, Lanari, Claudia, Radisky, Derek, Novaro, Virginia
Publicado no Oncotarget (2015)

Molecular mechanisms underlying AMH elevation in hyperoestrogenic states in males

Por Valeri, Clara, Lovaisa, María M., Racine, Chrystèle, Edelsztein, Nadia Y., Riggio, Marina, Giulianelli, Sebastián, Venara, Marcela, Bedecarrás, Patricia, Ballerini, María G., di Clemente, Nathalie, Lamb, Caroline A., Schteingart, Helena F., Rey, Rodolfo A.
Publicado no Sci Rep (2020)